Our Company

Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem manufactures and sells the t:slim X2™ Insulin Pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements. Tandem is based in San Diego, California.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tandem Diabetes Care's financial performance into perspective.

Stock Quote
+ 0.13
Day High:
Day Low:
4:00 PM ET on Oct 20, 2017

View all »   RSSRecent Releases

Oct 16, 2017
Tandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release and Conference Call

Oct 13, 2017
Tandem Diabetes Care Announces Pricing of $16.2 Million Underwritten Public Offering of Common Stock and Warrants

View all »Events & Presentations

Oct 26, 2017 at 1:30 PM PT
Q3 Tandem Diabetes Care 2017 Earnings